Laurus Labs Ltd.

NSE: LAURUSLABS | BSE: 540222

Expensive Star

Download real time

617.80 -2.75 (-0.44%)

60.28% Gain from 52W Low

1.8M NSE+BSE Volume

NSE 05 May, 2025 3:56 PM (IST)

1

Broker 1Year buys

1 active buys

0

Broker 1Year sells

0 active sells

3

Broker 1Year neutral

3 active holds

Dividend

Laurus Labs Ltd. has an upcoming dividend of ₹0.80 per share due on 09 May 2025 See details

Laurus Labs Ltd. share price target

Laurus Labs Ltd. has an average target of 633.50. The consensus estimate represents an upside of 2.54% from the last price of 617.80. View 12 reports from 4 analysts offering long-term price targets for Laurus Labs Ltd..

Reco - This broker has downgraded this stock from it's previous report.
(eg. - Buy->Hold)

Target - Broker has maintained previous recommendation but reduced share price target.

Reco - This broker has upgraded this stock from it's previous report.
(eg. - Sell->Hold)

Target - Broker has maintained previous recommendation but increased share price target.

Load latest Google or static link led you to an intermediate page.

Click on any table column to sort reports by date, stock name, broker, price, target, upside or recommendation.

Summary	Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report		Discuss
	05 May 2025	Laurus Labs	Consensus Share Price Target	617.80	564.93	-	-8.56	hold	pdf Detailed Estimates
	01 Dec 2023	Laurus Labs	KRChoksey	617.80	404.00	380.85 (62.22%)	Target met	Accumulate	pdf post cache		Broker Report Transforming into a high value non - ARV API and FDF, CDMO synthesis and Bio business KRChoksey Laurus Labs Ltd. (LAURUSLABS) is in the transformation phase by which it intends to reduce the share of ARV (FDF and API) businesses significantly and increase the share of other FDFs and APIs and CDMO synthesis and Biologics businesses. In the meantime, it has incurred over Rs. 26.0 Bn (average 16% of revenue) of capital investments over the last 3 years to augment capacity across generic APIs (non ARVs), FDF (non ARV), CDMO synthesis, and Bio businesses. pdf Copy Link Share on Share on Share on Share on Alert
	28 Nov 2023	Laurus Labs	KRChoksey	617.80	404.00	372.75 (65.74%)	Target met	Accumulate	pdf post cache		Broker Report Transforming into a high value non ARV API and FDF, CDMO synthesis and Bio business KRChoksey Laurus Labs Ltd. (LAURUSLABS) is in the transformation phase by which it intends to reduce the share of non-ARV (FDF and API) businesses significantly and increase the share of other FDFs and APIs and CDMO synthesis and Biologics businesses. In the meantime, it has incurred over Rs. 26.0 Bn (average 16% of revenue) of capital investments over the last 3 years to augment capacity across generic APIs (non ARVs), FDF (non ARV), CDMO synthesis, and Bio businesses. pdf Copy Link Share on Share on Share on Share on Alert
	23 Oct 2023	Laurus Labs	Keynote Capitals Ltd Target	617.80	447.00	362.40 (70.47%)	Target met	Buy	pdf post cache		Broker Report Laurus Labs Limited Keynote Capitals Ltd Quarterly Update Q2FY24 pdf Copy Link Share on Share on Share on Share on Alert
	20 Oct 2023	Laurus Labs	Sharekhan Reco Target	617.80	293.00	362.40 (70.47%)		Sell	pdf post cache		Broker Report Laurus Labs Sharekhan pdf Copy Link Share on Share on Share on Share on Alert
	31 Jul 2023	Laurus Labs	Keynote Capitals Ltd Target	617.80	402.00	352.00 (75.51%)	Target met	Buy	pdf post cache		Broker Report Laurus Labs Limited Keynote Capitals Ltd Quarterly Update Q1FY24 pdf Copy Link Share on Share on Share on Share on Alert
	02 May 2023	Laurus Labs	Keynote Capitals Ltd Target	617.80	383.00	311.60 (98.27%)	Target met	Buy	pdf post cache		Broker Report Laurus Labs Limited Keynote Capitals Ltd Quarterly Update Q4FY23 pdf Copy Link Share on Share on Share on Share on Alert
	28 Apr 2023	Laurus Labs	ICICI Direct Reco Target	617.80	300.00	307.60 (100.85%)	Target met	Hold	pdf post cache		Broker Report Laurus Labs ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	31 Mar 2023	Laurus Labs	Keynote Capitals Ltd	617.80	396.00	292.95 (110.89%)	Target met	Buy	pdf post cache		Broker Report Laurus Labs Limited Keynote Capitals Ltd Initiating Coverage Report pdf Copy Link Share on Share on Share on Share on Alert
	31 Jan 2023	Laurus Labs	ICICI Direct Target	617.80	400.00	330.30 (87.04%)	Target met	Buy	pdf post cache		Broker Report Laurus Labs ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	30 Jan 2023	Laurus Labs	Motilal Oswal Target	617.80	440.00	341.80 (80.75%)	Target met	Buy	pdf post cache		Broker Report Synthesis/Non-ARV API drives earnings Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
more loading

* Please note that subscribers can download a maximum of 300 reports a month and 70 reports everyday.

Advisor Screeners